Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization

scientific article

Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1090906287
P356DOI10.1007/S10815-017-1001-8
P932PMC publication ID5699982
P698PubMed publication ID28748493

P2093author name stringXiao Xu
Winifred Mak
Stephen C Collins
P2860cites workAbortion Incidence and Access to Services In the United States, 2008Q22306085
Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryosQ28831313
Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012Q31020106
Willingness to pay for a quality-adjusted life year: in search of a standardQ33993542
In vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43.Q35186895
Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention studyQ35974858
Selecting the optimal time to perform biopsy for preimplantation genetic testingQ38133071
Diagnosis of human preimplantation embryo viabilityQ38310795
Influence of race and ethnicity on in vitro fertilization outcomes: systematic reviewQ38585522
Validation of next-generation sequencing for comprehensive chromosome screening of embryosQ38823200
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled studyQ38825105
The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologistsQ38852215
Fresh versus frozen: initial transfer or cumulative cycle results: how do we interpret results and design studies?Q38870669
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and MedicineQ38953322
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY thresholdQ39268069
Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transferQ39409658
Mean Age of Mothers is on the Rise: United States, 2000-2014.Q40039112
Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial.Q41597588
Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery ratesQ45710307
Preimplantation genetic screening in older women: a cost-effectiveness analysis.Q46027773
Morphological and cytogenetic assessment of cleavage and blastocyst stage embryosQ46790679
Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy lossQ46922876
How do patient perceived determinants influence the decision-making process to accept or decline preimplantation genetic screening?Q47371065
The willingness to pay for in vitro fertilization: a pilot study using contingent valuationQ47561745
Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screeningQ48557679
Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies.Q51042727
Female age-related fertility decline. Committee Opinion No. 589.Q51158804
Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities.Q52206925
Mosaicism: "survival of the fittest" versus "no embryo left behind".Q53189736
In Vitro Fertilization with Preimplantation Genetic ScreeningQ59782826
Healthy Babies after Intrauterine Transfer of Mosaic Aneuploid BlastocystsQ60018989
Beyond usual care: the economic consequences of expanding treatment options in early pregnancy lossQ85222629
Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registryQ86840639
Preimplantation genetic screening: who benefits?Q89365141
P577publication date2017-07-27
P1433published inJournal of Assisted Reproduction and GeneticsQ15755113
P1476titleCost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization